Oncology drug development is a complex, high-stakes endeavor where every decision can significantly impact the success of a clinical trial.
One critical factor in improving outcomes is the ability to gain early and accurate insights into how a treatment affects tumors and their microenvironment.
Advanced imaging techniques, especially when applied early in oncology trials, offer a powerful way to gather this information.
Early imaging insights can lead to better-defined trial endpoints, more efficient trials, and ultimately, faster paths to regulatory approval and patient benefit. The Challenge of Oncology Trial Endpoints Endpoints in oncology trials serve as benchmarks for assessing a treatment’s effectiveness.
Read more on curiousmindmagazine.com